In vitro activity of the new semi-synthetic polypeptide cilofungin (LY121019) againstAspergillus andCandida species

Aspergillosis complicating neoplastic disease

Richard D. Meyer, Lowell S. Young, Donald Armstrong et al. · The American Journal of Medicine · 1973 · 530 citations

Veterinary Medicine, Infectious Diseases, Microbiology +12

Manual of Clinical Microbiology

Judith A. Kepler · American Journal of Health-System Pharmacy · 1975 · 500 citations

Life Sciences, Infectious Diseases, Microbiology +12

Fungemia in a Cancer Hospital: Changing Frequency, Earlier Onset, and Results of Therapy

Robert G. Horn, Brian W. Wong, T. E. Kiehn et al. · Clinical Infectious Diseases · 1985 · 489 citations

Medicine, Infectious Diseases, Oncology +13

Papulacandin B: an Inhibitor of Glucan Synthesis in Yeast Spheroplasts

Bruce C. Baguley, GÜNTER RÖMMELE, J. Gruner et al. · European Journal of Biochemistry · 1979 · 135 citations · Full text

Life Sciences, Biochemistry, Microbiology +17

In vitro and in vivo anti-Candida activity and toxicology of LY121019.

Robert S. Gordee, Douglas J. Zeckner, L. F. Ellis et al. · The Journal of Antibiotics · 1984 · 109 citations · Full text

Life Sciences, Immunology, Toxicology +12